Lab abnormalities.
. | Myeloid blast crisis . | Accelerated phase . | Chronic phase, interferon failure . | |||
---|---|---|---|---|---|---|
. | n = 260 . | n = 235 . | n = 532 . | |||
. | (%) . | (%) . | (%) . | |||
. | Grade 3 . | Grade 4 . | Grade 3 . | Grade 4 . | Grade 3 . | Grade 4 . |
CTC grades: neutropenia (grade 3 ≥ 0.5 – 1.0 x 109/L, grade 4 < 0.5 x 109/L), thrombocytopenia (grade 3 ≥ 10 – 50 x 109/L, grade 4 < 10 x 109/L), anemia (hemoglobin ≥ 65 – 80 g/L, grade 4 < 65 g/L), elevated creatinine (grade 3 > 3-6 x upper limit normal range (ULN), grade 4 > 6 x ULN), elevated bilirubin (grade 3 > 3-10 x ULN, grade 4 > 10 x ULN), elevated alkaline phosphatase (grade 3 > 5-20 x ULN, grade 4 > 20 x ULN), elevated SGOT or SGPT (grade 3 > 5-20 x ULN, grade 4 > 20 x ULN). According to protocol, treatment was interrupted for > Grade 3 or neutropenia or thrombocytopenia in chronic phase patients. Guidelines for accelerated and blast patients were as noted in the text. | ||||||
Hematology parameters | ||||||
• Neutropenia | 16 | 47 | 23 | 35 | 26 | 8 |
• Thrombocytopenia | 27 | 33 | 31 | 12 | 17 | <1 |
• Anemia | 40 | 11 | 33 | 6 | 5 | <1 |
Biochemistry parameters | ||||||
• Elevated creatinine | 1.2 | 0 | 1.3 | 0 | 0.2 | 0 |
• Elevated bilirubin | 3.5 | 0 | 1.7 | 0 | 0.6 | 0 |
• Elevated alkaline phosphatase | 4.6 | 0 | 5.1 | 0.4 | 0.2 | 0 |
• Elevated SGOT (AST) | 1.9 | 0 | 2.1 | 0 | 1.7 | 0 |
• Elevated SGPT (ALT) | 2.3 | 0.4 | 3.0 | 0 | 1.7 | 0 |
. | Myeloid blast crisis . | Accelerated phase . | Chronic phase, interferon failure . | |||
---|---|---|---|---|---|---|
. | n = 260 . | n = 235 . | n = 532 . | |||
. | (%) . | (%) . | (%) . | |||
. | Grade 3 . | Grade 4 . | Grade 3 . | Grade 4 . | Grade 3 . | Grade 4 . |
CTC grades: neutropenia (grade 3 ≥ 0.5 – 1.0 x 109/L, grade 4 < 0.5 x 109/L), thrombocytopenia (grade 3 ≥ 10 – 50 x 109/L, grade 4 < 10 x 109/L), anemia (hemoglobin ≥ 65 – 80 g/L, grade 4 < 65 g/L), elevated creatinine (grade 3 > 3-6 x upper limit normal range (ULN), grade 4 > 6 x ULN), elevated bilirubin (grade 3 > 3-10 x ULN, grade 4 > 10 x ULN), elevated alkaline phosphatase (grade 3 > 5-20 x ULN, grade 4 > 20 x ULN), elevated SGOT or SGPT (grade 3 > 5-20 x ULN, grade 4 > 20 x ULN). According to protocol, treatment was interrupted for > Grade 3 or neutropenia or thrombocytopenia in chronic phase patients. Guidelines for accelerated and blast patients were as noted in the text. | ||||||
Hematology parameters | ||||||
• Neutropenia | 16 | 47 | 23 | 35 | 26 | 8 |
• Thrombocytopenia | 27 | 33 | 31 | 12 | 17 | <1 |
• Anemia | 40 | 11 | 33 | 6 | 5 | <1 |
Biochemistry parameters | ||||||
• Elevated creatinine | 1.2 | 0 | 1.3 | 0 | 0.2 | 0 |
• Elevated bilirubin | 3.5 | 0 | 1.7 | 0 | 0.6 | 0 |
• Elevated alkaline phosphatase | 4.6 | 0 | 5.1 | 0.4 | 0.2 | 0 |
• Elevated SGOT (AST) | 1.9 | 0 | 2.1 | 0 | 1.7 | 0 |
• Elevated SGPT (ALT) | 2.3 | 0.4 | 3.0 | 0 | 1.7 | 0 |